Back to Single Peptide Protocols
Single PeptideGrowth Hormone & Performance5 mg vial2–3× dailySubcutaneousGH Secretagogue
Ipamorelin (5 mg Vial) Dosage Protocol
Ipamorelin dosage protocol for the 5 mg vial. Selective GH secretagogue with pulsatile dosing schedule and cycle guidance.
Vial Size
5 mg
Route
Subcutaneous
Frequency
2–3× daily (pulsatile)
Dose Range
100–300 mcg per injection
Dosage Schedule
| Period | Dose |
|---|---|
| Weeks 1–2 (starter) | 100 mcg per injection |
| Weeks 3+ (maintenance) | 200–300 mcg per injection |
Route: Subcutaneous · Frequency: 2–3× daily (pulsatile) · Cycle: 8–12 weeks
How It Works
Ipamorelin is a selective growth hormone secretagogue and ghrelin receptor agonist. It stimulates pulsatile GH release with minimal effect on cortisol or prolactin, making it one of the cleanest GH secretagogues available.
Potential Benefits
- •Selective GH pulse stimulation with minimal cortisol/prolactin elevation.
- •Supports lean muscle mass and fat metabolism.
- •Improves sleep quality and recovery.
- •Well-tolerated in clinical studies.
Side Effects & Risks
- •Mild water retention at higher doses.
- •Transient headache or flushing.
- •Prohibited by WADA in competitive sports.
Important Notes
- Administer on an empty stomach for optimal GH pulse.
- Best administered before bed to coincide with natural GH release.
- WADA prohibits in competitive sports.
Storage Instructions
- Lyophilized: −20 °C (−4 °F).
- Once mixed: 2–8 °C; use within 14–21 days.
References
- [1]Raun K et al. Ipamorelin, the first selective growth hormone secretagogue. Eur J Endocrinol 1998.View Source
Research & Educational Use Only: This protocol is for educational and research purposes only. It does not constitute medical advice, diagnosis, or treatment. Always consult a qualified healthcare professional before making any decisions related to peptides or any other compounds.